Chronic Active T-Cell Mediated Kidney Rejection as a Clinically Significant Type of Allograft Loss?

Area of Science:

• Nephrology
• Transplantation Immunology
• Pathology

Background:

• Chronic active T-cell mediated rejection (CA TCMR) is a significant concern in kidney transplantation.
• Understanding CA TCMR is crucial for improving long-term allograft survival.

Purpose of the Study:

• To review current knowledge on chronic active T-cell mediated rejection (CA TCMR) in kidney allografts.
• To evaluate diagnostic criteria, molecular methods, and treatment strategies for CA TCMR.
• To explore the impact of coexisting rejection types and non-HLA antibodies on CA TCMR.

Main Methods:

• Literature review of current diagnostic criteria (Banff classification).
• Analysis of molecular diagnostic tools for kidney rejection.
• Assessment of existing and novel therapeutic interventions for CA TCMR.
• Investigation into the interplay between CA TCMR, antibody-mediated rejection (ABMR), and non-HLA antibodies.

Main Results:

• Current Banff criteria for kidney rejection are under review for potential evolution.
• Molecular methods show promise for integration into diagnostic schemes.
• Treatment strategies for CA TCMR have associated side effects.
• Coexistence of CA TCMR with ABMR and non-HLA antibodies complicates management and impacts allograft function.

Conclusions:

• Existing knowledge on CA TCMR is insufficient, necessitating further research.
• Optimizing diagnostic and therapeutic approaches for CA TCMR is critical.
• Understanding the influence of coexisting immunological factors is essential for patient outcomes.